We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bayer was glad to participate in the advisory committee meeting held by the Cardiovascular and Renal Drugs Division of the U.S. Food and Drug Administration.
Medical research and services company Charles River Laboratories International Inc. said Friday it received a $111.6 million grant from the National Cancer Institute.
More than a year after losing the first trial over its withdrawn painkiller Vioxx, drugmaker Merck & Co. is appealing a court judgment that awarded $26.1 million to the plaintiff.
Bristol-Myers Squibb and Sanofi-Aventis said on Thursday that a U.S. appeals court denied a motion to stay a preliminary injunction ordering Apotex Inc. to halt its sales of a generic version of top-selling blood-thinner Plavix.
Par Pharmaceutical will be able to launch a version of Unimed Pharmaceuticals' testosterone-replacement product AndroGel more than four years before patent expiration under terms of a settlement the announced by the companies.
In response to a rising number of pediatric clinical trials, the FDA is adding an ethicist to the staff of its Office of Pediatric Therapeutics in an effort to ensure protections for children.
The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Northern District of California on behalf of all persons who purchased the publicly traded securities of Connetics Corporation (the Company'') between June 28, 2004 and May 3, 2006, inclusive, (the Class Period'').